NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea · Delayed Price · Currency is KRW 1,316.00
-7.00 (-0.53%)
Jun 30, 2026, 3:30 PM KST
NeoImmuneTech Market Cap
NeoImmuneTech has a market cap or net worth of 130.11 billion as of June 30, 2026. Its market cap has decreased by -73.71% in one year.
Market Cap
130.11B
Enterprise Value
83.19B
Revenue
608.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,316.00
Market Cap Chart
Since March 16, 2021, NeoImmuneTech's market cap has decreased from 7.32T to 130.11B, a decrease of -98.22%. That is a compound annual growth rate of -53.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 130.11B | -67.94% |
| Dec 30, 2025 | 405.85B | -27.02% |
| Dec 30, 2024 | 556.13B | -44.44% |
| Dec 28, 2023 | 1.00T | -49.29% |
| Dec 29, 2022 | 1.97T | -61.23% |
| Dec 30, 2021 | 5.09T | -30.48% |
| Mar 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anterogen.Co.,Ltd. | 207.13B |
| EASY BIO,Inc. | 196.84B |
| HLB Therapeutics | 191.61B |
| Bioneer | 181.70B |
| JETEMA, | 181.22B |
| Helixmith | 169.45B |
| Macrogen | 126.74B |
| Genexine | 120.52B |